Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).

Phung KT, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Søgaard R, Sørensen LV, Vogel A, Waldemar G.

BMJ Open. 2013 Nov 21;3(11):e003584. doi: 10.1136/bmjopen-2013-003584.

2.

Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY).

Waldorff FB, Buss DV, Eckermann A, Rasmussen ML, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A, Waldemar G.

BMJ. 2012 Jul 17;345:e4693. doi: 10.1136/bmj.e4693.

3.

Proxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study.

Vogel A, Bhattacharya S, Waldorff FB, Waldemar G.

Int Psychogeriatr. 2012 Jan;24(1):82-9. doi: 10.1017/S1041610211001128. Epub 2011 Jun 28.

PMID:
21729415
4.

Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY).

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Phung KT, Waldemar G; DAISY Study Investigators.

BMJ Open. 2014 Jan 15;4(1):e004105. doi: 10.1136/bmjopen-2013-004105.

5.

Discrepancy between self- and proxy-rated pain in Alzheimer's disease: results from the Danish Alzheimer Intervention Study.

Jensen-Dahm C, Vogel A, Waldorff FB, Waldemar G.

J Am Geriatr Soc. 2012 Jul;60(7):1274-8. doi: 10.1111/j.1532-5415.2012.04036.x. Epub 2012 Jun 15.

PMID:
22702408
6.

Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up.

Koivisto AM, Hallikainen I, Välimäki T, Hongisto K, Hiltunen A, Karppi P, Sivenius J, Soininen H, Martikainen J.

Int J Geriatr Psychiatry. 2016 Mar;31(3):273-83. doi: 10.1002/gps.4321. Epub 2015 Jul 14.

PMID:
26177825
7.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

8.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

9.

REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial.

Woods RT, Bruce E, Edwards RT, Elvish R, Hoare Z, Hounsome B, Keady J, Moniz-Cook ED, Orgeta V, Orrell M, Rees J, Russell IT.

Health Technol Assess. 2012;16(48):v-xv, 1-116. doi: 10.3310/hta16480.

10.

Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Naglie G, Hogan DB, Krahn M, Black SE, Beattie BL, Patterson C, Macknight C, Freedman M, Borrie M, Byszewski A, Bergman H, Streiner D, Irvine J, Ritvo P, Comrie J, Kowgier M, Tomlinson G.

Am J Geriatr Psychiatry. 2011 Oct;19(10):891-901. doi: 10.1097/JGP.0b013e3182006a7f.

11.

START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.

Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D, Livingston D, Lewis-Holmes E, Mummery C, Walker Z, Hoe J, Cooper C.

Health Technol Assess. 2014 Oct;18(61):1-242. doi: 10.3310/hta18610.

12.

Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.

Hongisto K, Hallikainen I, Selander T, Törmälehto S, Väätäinen S, Martikainen J, Välimäki T, Hartikainen S, Suhonen J, Koivisto AM.

Int J Geriatr Psychiatry. 2017 Jan 9. doi: 10.1002/gps.4666. [Epub ahead of print]

PMID:
28067961
13.

Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study.

de Rotrou J, Cantegreil I, Faucounau V, Wenisch E, Chausson C, Jegou D, Grabar S, Rigaud AS.

Int J Geriatr Psychiatry. 2011 Aug;26(8):833-42. doi: 10.1002/gps.2611. Epub 2010 Oct 4.

PMID:
20922772
14.

Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial.

Orgeta V, Leung P, Yates L, Kang S, Hoare Z, Henderson C, Whitaker C, Burns A, Knapp M, Leroi I, Moniz-Cook ED, Pearson S, Simpson S, Spector A, Roberts S, Russell IT, de Waal H, Woods RT, Orrell M.

Health Technol Assess. 2015 Aug;19(64):1-108. doi: 10.3310/hta19640.

15.

Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial.

Callahan CM, Boustani MA, Schmid AA, Austrom MG, Miller DK, Gao S, Morris CS, Vogel M, Hendrie HC.

Trials. 2012 Jun 27;13:92. doi: 10.1186/1745-6215-13-92.

16.

A cluster randomised controlled trial and economic evaluation of a structured training programme for caregivers of inpatients after stroke: the TRACS trial.

Forster A, Dickerson J, Young J, Patel A, Kalra L, Nixon J, Smithard D, Knapp M, Holloway I, Anwar S, Farrin A; TRACS Trial Collaboration.

Health Technol Assess. 2013 Oct;17(46):1-216. doi: 10.3310/hta17460.

17.

REMCARE: Pragmatic Multi-Centre Randomised Trial of Reminiscence Groups for People with Dementia and their Family Carers: Effectiveness and Economic Analysis.

Woods RT, Orrell M, Bruce E, Edwards RT, Hoare Z, Hounsome B, Keady J, Moniz-Cook E, Orgeta V, Rees J, Russell I.

PLoS One. 2016 Apr 19;11(4):e0152843. doi: 10.1371/journal.pone.0152843. eCollection 2016.

18.

Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Naglie G, Hogan DB, Krahn M, Beattie BL, Black SE, Macknight C, Freedman M, Patterson C, Borrie M, Bergman H, Byszewski A, Streiner D, Irvine J, Ritvo P, Comrie J, Kowgier M, Tomlinson G.

Am J Geriatr Psychiatry. 2011 Oct;19(10):881-90. doi: 10.1097/JGP.0b013e3182006a67.

19.

Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.

Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC.

JAMA. 2006 May 10;295(18):2148-57.

PMID:
16684985
20.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

Supplemental Content

Support Center